Ceribell, Inc. Files S-1/A Amendment for IPO

Ticker: CBLL · Form: S-1/A · Filed: Oct 7, 2024 · CIK: 1861107

Ceribell, INC. S-1/A Filing Summary
FieldDetail
CompanyCeribell, INC. (CBLL)
Form TypeS-1/A
Filed DateOct 7, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$14.00, $16.00, $2 billion, $45.2 million, $25.9 million
Sentimentneutral

Sentiment: neutral

Topics: ipo, sec-filing, amendment

TL;DR

Ceribell IPO update: S-1/A filed Oct 7. Looks like they're still aiming for public markets.

AI Summary

Ceribell, Inc. filed an S-1/A amendment on October 7, 2024, for its initial public offering. The company, incorporated in Delaware, is seeking to register an unspecified number of shares under the Securities Act of 1933. Its principal executive offices are located at 360 N. Pastoria Avenue, Sunnyvale, California.

Why It Matters

This filing indicates Ceribell, Inc. is moving forward with its plan to become a publicly traded company, which could impact its future funding and growth trajectory.

Risk Assessment

Risk Level: medium — As an S-1/A filing, it represents a company in the process of going public, which inherently carries market and execution risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1/A filing?

This is an amendment (Amendment No. 2) to the Form S-1 Registration Statement filed by Ceribell, Inc. under the Securities Act of 1933, indicating updates or revisions to their initial public offering plans.

When was this amendment filed?

This amendment was filed with the U.S. Securities and Exchange Commission on October 7, 2024.

Where is Ceribell, Inc. headquartered?

Ceribell, Inc.'s principal executive offices are located at 360 N. Pastoria Avenue, Sunnyvale, California, 94085.

Who are the key executives mentioned in the filing?

Jane Chao, Ph.D. is listed as the President, Chief Executive Officer and Co-Founder of Ceribell, Inc.

What is the SEC file number associated with this registration?

The SEC file number for this registration is 333-281784.

Filing Stats: 4,385 words · 18 min read · ~15 pages · Grade level 15.2 · Accepted 2024-10-07 06:19:42

Key Financial Figures

Filing Documents

Description of Capital Stock

Description of Capital Stock 162 Special Note Regarding Forward-Looking Statements 59 Shares Eligible for Future Sale 167 Material U.S. Federal Income Tax Consequences to Non-U.S. Holders 170 Market and Industry Data 61

Use of Proceeds

Use of Proceeds 62

UNDERWRITING

UNDERWRITING 173 Dividend Policy 63 Legal Matters 180 Capitalization 64 Experts 180

Dilution

Dilution 66 Where You Can Find Additional Information 180 Management’s Discussion and Analysis of Financial Condition and Results of Operations 69 CHANGE IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 180

Business

Business 88 Index to Financial Statements F- 1 Management 135 As used in this prospectus, unless the context otherwise requires, references to “Ceribell,” the “company,” “we,” “us,” and “our” refer to CeriBell, Inc. “Ceribell,” the Ceribell logos, and other trade names, trademarks, or service marks of Ceribell appearing in this prospectus are the property of Ceribell. Other trade names, trademarks, or service marks appearing in this prospectus are the property of their respective holders. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us, by these other companies. Solely for convenience, trade names, trademarks, and service marks referred to in this prospectus appear without the , , and SM symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade names, trademarks, and service marks. Numerical figures included in this prospectus have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them. We have not, and the underwriters have not, authorized anyone to provide you any information or to make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the underwriters take responsibility for, or provide any assurance as to the reliability of, any other information others may give you. This prospectus is an offer to sell only the shares offered hereby, and only under circumstances and in jurisdictions where it is lawful to do so. We are not, and the underw

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing